228 related articles for article (PubMed ID: 9217190)
1. Avascular necrosis of bone after allogeneic bone marrow transplantation: analysis of risk factors for 4388 patients by the Société Française de Greffe de Moëlle (SFGM).
Socié G; Cahn JY; Carmelo J; Vernant JP; Jouet JP; Ifrah N; Milpied N; Michallet M; Lioure B; Pico JL; Witz F; Molina L; Fischer A; Bardou VJ; Gluckman E; Reiffers J
Br J Haematol; 1997 Jun; 97(4):865-70. PubMed ID: 9217190
[TBL] [Abstract][Full Text] [Related]
2. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors.
Socié G; Sélimi F; Sedel L; Frija J; Devergie A; Esperou Bourdeau H; Ribaud P; Gluckman E
Br J Haematol; 1994 Mar; 86(3):624-8. PubMed ID: 8043445
[TBL] [Abstract][Full Text] [Related]
3. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation.
Enright H; Haake R; Weisdorf D
Am J Med; 1990 Dec; 89(6):733-8. PubMed ID: 2252042
[TBL] [Abstract][Full Text] [Related]
4. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Société Française de Greffe de moelle (SFGM).
Michallet M; Tanguy ML; Socié G; Thiébaut A; Belhabri A; Milpied N; Reiffers J; Kuentz M; Cahn JY; Blaise D; Demeocq F; Jouet JP; Michallet AS; Ifrah N; Vilmer E; Molina L; Michel G; Lioure B; Cavazzana-Calvo M; Pico JL; Sadoun A; Guyotat D; Attal M; Curé H; Bordigoni P; Sutton L; Buzyn-Veil A; Tilly M; Keoirruer N; Feguex N
Br J Haematol; 2000 Feb; 108(2):400-7. PubMed ID: 10691873
[TBL] [Abstract][Full Text] [Related]
5. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for outcomes after reduced intensity conditioning hematopoietic stem cell transplantation for hematological malignancies: a 10-year retrospective analysis from the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Michallet M; Le QH; Mohty M; Prébet T; Nicolini F; Boiron JM; Esperou H; Attal M; Milpied N; Lioure B; Bordigoni P; Yakoub-Agha I; Bourhis JH; Rio B; Deconinck E; Renaud M; Chir Z; Blaise D
Exp Hematol; 2008 May; 36(5):535-44. PubMed ID: 18346838
[TBL] [Abstract][Full Text] [Related]
7. Impact of Thymoglobulin by Stem Cell Source (Peripheral Blood Stem Cell or Bone Marrow) After Myeloablative Stem Cell Transplantation From HLA 10/10-Matched Unrelated Donors: A Report From the Société Française de Greffe de Moelle et de Thérapie Cellulaire.
Ravinet A; Cabrespine A; Socié G; Milpied N; Yakoub Agha I; Nguyen S; Michallet M; Menard AL; Maillard N; Mohty M; Suarez F; Huynh A; Marchand T; Deteix C; Cassuto JP; Maury S; Chevallier P; Reman O; Peffault de Latour R; Bay JO
Transplantation; 2016 Aug; 100(8):1732-9. PubMed ID: 26528768
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic bone marrow transplantation remains an efficient consolidation for adults with acute myeloid leukemia even when performed very soon after diagnosis (< 100 days). The SFGM (Société Française de Greffe de Moelle.
Jourdan E; Maraninchi D; Reiffers J; Archimbaud E; Michallet M; Harousseau JL; Ifrah N; Rio B; Guyotat D; Guilhot F
Leukemia; 1995 Jun; 9(6):1068-71. PubMed ID: 7596171
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic bone marrow transplantation for chronic myeloid leukemia in childhood: a report from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Millot F; Esperou H; Bordigoni P; Dalle JH; Michallet M; Michel G; Bourhis JL; Kuenz M; Blaise D; Garban F; Plouvier E; Rome A; Guilhot J; Guilhot F
Bone Marrow Transplant; 2003 Nov; 32(10):993-9. PubMed ID: 14595387
[TBL] [Abstract][Full Text] [Related]
10. Early allogeneic transplantation favorably influences the outcome of adult patients suffering from acute myeloid leukemia. Société Française de Greffe de Moelle (SFGM).
Jourdan E; Maraninchi D; Reiffers J; Gluckman E; Rio B; Jouet JP; Michallet M; Molina L; Archimbaud E; Harousseau JL; Ifrah N; Attal M; Guilhot F; Kuentz M; Guyotat D; Pico JL; Dauriac C; Legros M; Dreyfus F; Bordigoni P; Leblond V; Gratecos N; Varet B; Auzanneau C; Blaise D
Bone Marrow Transplant; 1997 May; 19(9):875-81. PubMed ID: 9156260
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic bone marrow transplantation in aggressive non-Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database. Sociét Française de Greffe de Moelle.
Dhedin N; Giraudier S; Gaulard P; Esperou H; Ifrah N; Michallet M; Milpied N; Rio B; Cahn JY; Molina L; Laporte JL; Guilhot F; Kuentz M
Br J Haematol; 1999 Oct; 107(1):154-61. PubMed ID: 10520036
[TBL] [Abstract][Full Text] [Related]
12. Avascular necrosis of bone after allogeneic hematopoietic cell transplantation in children and adolescents.
Li X; Brazauskas R; Wang Z; Al-Seraihy A; Baker KS; Cahn JY; Frangoul HA; Gajewski JL; Hale GA; Hsu JW; Kamble RT; Lazarus HM; Marks DI; Maziarz RT; Savani BN; Shah AJ; Shah N; Sorror ML; Wood WA; Majhail NS
Biol Blood Marrow Transplant; 2014 Apr; 20(4):587-92. PubMed ID: 24388803
[TBL] [Abstract][Full Text] [Related]
13. Improvement in outcome for children receiving allogeneic bone marrow transplantation in first remission of acute myeloid leukemia: a report from the Groupe d'Etude des Greffes de Moelle Osseuse.
Michel G; Gluckman E; Blaise D; Esperou-Bourdeau H; Vernant JP; Kuentz M; Bordigoni P; Milpied N; Rubie H; Thuret I
J Clin Oncol; 1992 Dec; 10(12):1865-9. PubMed ID: 1453201
[TBL] [Abstract][Full Text] [Related]
14. Chronic graft-versus-host disease after allogeneic bone marrow transplantation from an unrelated donor: incidence, risk factors and association with relapse. A report from the Japan Marrow Donor Program.
Ozawa S; Nakaseko C; Nishimura M; Maruta A; Cho R; Ohwada C; Sakamaki H; Sao H; Mori S; Okamoto S; Miyamura K; Kato S; Kawase T; Morishima Y; Kodera Y;
Br J Haematol; 2007 Apr; 137(2):142-51. PubMed ID: 17391494
[TBL] [Abstract][Full Text] [Related]
15. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
Robin M; Guardiola P; Dombret H; Baruchel A; Esperou H; Ribaud P; Devergie A; Gluckman E; Socié G
Bone Marrow Transplant; 2003 May; 31(10):877-87. PubMed ID: 12748664
[TBL] [Abstract][Full Text] [Related]
16. Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).
Fabre C; Koscielny S; Mohty M; Fegueux N; Blaise D; Maillard N; Tabrizi R; Michallet M; Socié G; Yakoub-Agha I; Garban F; Uzunov M; François S; Contentin N; Lapusan S; Bourhis JH
Haematologica; 2012 Apr; 97(4):482-90. PubMed ID: 22058218
[TBL] [Abstract][Full Text] [Related]
17. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft.
Herrera C; Torres A; García-Castellano JM; Roman J; Martin C; Serrano J; Falcon M; Alvarez MA; Gomez P; Martinez F
Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557
[TBL] [Abstract][Full Text] [Related]
18. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
Soiffer RJ; Mauch P; Fairclough D; Alyea E; Anderson K; Fisher D; Freedman A; Bartlett-Pandite L; Robertson M; Schlossman R; Gollob J; Marcus K; Murray C; Kuhlman C; Freeman A; Nadler L; Ritz J
Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736
[TBL] [Abstract][Full Text] [Related]
19. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.
Mohty M; Labopin M; Balère ML; Socié G; Milpied N; Tabrizi R; Ifrah N; Hicheri Y; Dhedin N; Michallet M; Buzyn A; Cahn JY; Bourhis JH; Blaise D; Raffoux C; Espérou H; Yakoub-Agha I
Leukemia; 2010 Nov; 24(11):1867-74. PubMed ID: 20882046
[TBL] [Abstract][Full Text] [Related]
20. Prior treatment with alpha interferon does not adversely affect the outcome of allogeneic transplantation for chronic myeloid leukaemia.
Pigneux A; Tanguy ML; Michallet M; Jouet JP; Kuentz M; Vernant JP; Milpied N; Ifrah N; Cahn JY; Gratecos N; Reman O; Cure H; Caillot D; Witz F; Pillier-Loriette C; Tron P; Reiffers J;
Br J Haematol; 2002 Jan; 116(1):193-201. PubMed ID: 11841417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
